Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients

被引：4
|
作者：
Derijks, L. J. J. [1 ]
van Helden, R. B. [2 ]
Hommes, D. W. [2 ]
Stokkers, P. C. [3 ]
机构：
[1] Maxima Med Ctr, Dept Clin Pharm, NL-5500 MB Veldhoven, Netherlands
[2] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
来源：
GUT | 2008年 / 57卷 / 06期
关键词：
D O I：
10.1136/gut.2007.145912
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：872 / 872
页数：1
相关论文
共 50 条
  • [1] Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine
    Kaskas, BA
    Louis, E
    Hindorf, U
    Schaeffeler, E
    Deflandre, J
    Graepler, F
    Schmiegelow, K
    Gregor, M
    Zanger, UM
    Eichelbaum, M
    Schwab, M
    [J]. GUT, 2003, 52 (01) : 140 - 142
  • [2] Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease
    Takatsu, Noritaka
    Matsui, Toshiyuki
    Murakami, Yuji
    Ishihara, Hiroshi
    Hisabe, Takashi
    Nagahama, Takashi
    Maki, Shinichirou
    Beppu, Takahiro
    Takaki, Yasuhiro
    Hirai, Fumihito
    Yao, Kenshi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (07) : 1258 - 1264
  • [3] Genetic polymorphisms of the thiopurine S-methyltransferase (TPMT) locus in patients treated with azathioprine for inflammatory bowel disease.
    Rietdijk, ST
    Bartelsman, J
    Hommes, DW
    Vogels, E
    Reitsma, PH
    Van Deventer, SJH
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A622 - A622
  • [4] No predictive value of thiopurine S-methyltransferase genotyping for adverse events in inflammatory bowel disease patients established on azathioprine
    Derijks, LJJ
    Curvers, WL
    Hooymans, PM
    van Deventer, SJH
    Hommes, DW
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 105 - 105
  • [5] Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease:: impact of thiopurine S-methyltransferase polymorphism
    Schwab, M
    Schäffeler, E
    Marx, C
    Fischer, C
    Lang, T
    Behrens, C
    Gregor, M
    Eichelbaum, M
    Zanger, UM
    Kaskas, BA
    [J]. PHARMACOGENETICS, 2002, 12 (06): : 429 - 436
  • [6] Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease
    Dong, Xian-Wen
    Zheng, Qing
    Zhu, Ming-Ming
    Tong, Jing-Lu
    Ran, Zhi-Hua
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (25) : 3187 - 3195
  • [7] Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease
    Xian-Wen Dong
    [J]. World Journal of Gastroenterology, 2010, 16 (25) : 3187 - 3195
  • [8] Analysis of Thiopurine S-Methyltransferase Genotypes in Japanese Patients with Inflammatory Bowel Disease
    Ban, Hiromitsu
    Andoh, Akira
    Tanaka, Aiko
    Tsujikawa, Tomoyuki
    Sasaki, Masaya
    Saito, Yasuharu
    Fujiyama, Yoshihide
    [J]. INTERNAL MEDICINE, 2008, 47 (19) : 1645 - 1648
  • [9] Thiopurine methyltransferase genotype and thiopurine S-methyltransferase activity in Greek children with inflammatory bowel disease
    Gazouli, Maria
    Pachoula, Ioanna
    Panayotou, Ioanna
    Chouliaras, Georgios
    Anagnou, Nicholas P.
    Chroussos, George
    Roma, Eleftheria
    [J]. ANNALS OF GASTROENTEROLOGY, 2012, 25 (03): : 249 - 253
  • [10] Thiopurine S-methyltransferase activity in inflammatory bowel disease: A retrospective study
    Hassan, C
    Duley, J
    Ansari, A
    Shobowale-Bakre, EM
    Reffitt, D
    Meenan, J
    Sanderson, J
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A733 - A733
12345